BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10779556)

  • 21. DNA vaccines against HPV-16 E7-expressing tumour cells.
    De Marco F; Hallez S; Brulet JM; Gesché F; Marzano P; Flamini S; Marcante ML; Venuti A
    Anticancer Res; 2003; 23(2B):1449-54. PubMed ID: 12820408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective and therapeutic antitumour immunity using a novel tumour-associated antigen-specific DNA vaccine.
    Sun W; Qian H; Zhang X; Zhou C; Liang X; Wang D; Fu M; Ma W; Zhang S; Lin C
    Immunol Cell Biol; 2006 Oct; 84(5):440-7. PubMed ID: 16942487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte.
    Zhang M; Obata C; Hisaeda H; Ishii K; Murata S; Chiba T; Tanaka K; Li Y; Furue M; Chou B; Imai T; Duan X; Himeno K
    Gene Ther; 2005 Jul; 12(13):1049-57. PubMed ID: 15800663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
    Zhou WZ; Kaneda Y; Huang S; Morishita R; Hoon D
    Gene Ther; 1999 Oct; 6(10):1768-73. PubMed ID: 10516727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
    Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.
    Ribas A; Butterfield LH; Hu B; Dissette VB; Chen AY; Koh A; Amarnani SN; Glaspy JA; McBride WH; Economou JS
    J Immunother; 2000 Jan; 23(1):59-66. PubMed ID: 10687138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo.
    Wagner SN; Wagner C; Lührs P; Weimann TK; Kutil R; Goos M; Stingl G; Schneeberger A
    J Invest Dermatol; 2000 Dec; 115(6):1082-7. PubMed ID: 11121145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae.
    Pinchuk I; Starcher BC; Livingston B; Tvninnereim A; Wu S; Appella E; Sidney J; Sette A; Wizel B
    J Immunol; 2005 May; 174(9):5729-39. PubMed ID: 15843575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effect of a combined DNA and peptide vaccine against gp100 in a malignant melanoma mouse model.
    Nawrath M; Pavlovic J; Moelling K
    J Mol Med (Berl); 2001 Apr; 79(2-3):133-42. PubMed ID: 11357937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining DNA Vaccine and AIDA-1 in Attenuated
    Mei Y; Zhao L; Liu Y; Gong H; Song Y; Lei L; Zhu Y; Jin Z; Ma S; Hu B; Sun Q; Liu H
    Cancer Immunol Res; 2017 Jun; 5(6):503-514. PubMed ID: 28468915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
    Schreurs MW; Eggert AA; de Boer AJ; Vissers JL; van Hall T; Offringa R; Figdor CG; Adema GJ
    Cancer Res; 2000 Dec; 60(24):6995-7001. PubMed ID: 11156402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.
    Hawkins WG; Gold JS; Dyall R; Wolchok JD; Hoos A; Bowne WB; Srinivasan R; Houghton AN; Lewis JJ
    Surgery; 2000 Aug; 128(2):273-80. PubMed ID: 10923004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
    Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1.
    Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
    J Clin Immunol; 2007 Jan; 27(1):117-30. PubMed ID: 17180470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response.
    Ji Q; Gondek D; Hurwitz AA
    J Immunol; 2005 Aug; 175(3):1456-63. PubMed ID: 16034082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.
    Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG
    Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects.
    Faham A; Herringson T; Parish C; Suhrbier A; Khromykh AA; Altin JG
    Vaccine; 2011 Sep; 29(40):6911-9. PubMed ID: 21798298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.